A virtual screen identified C96 as a novel inhibitor of phosphatidylinositol 3-kinase that displays potent preclinical activity against multiple myeloma in vitro and in vivo
about
A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myelomaSynergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.Kinase inhibitors as potential agents in the treatment of multiple myeloma.Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways
P2860
A virtual screen identified C96 as a novel inhibitor of phosphatidylinositol 3-kinase that displays potent preclinical activity against multiple myeloma in vitro and in vivo
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
A virtual screen identified C9 ...... e myeloma in vitro and in vivo
@ast
A virtual screen identified C9 ...... e myeloma in vitro and in vivo
@en
type
label
A virtual screen identified C9 ...... e myeloma in vitro and in vivo
@ast
A virtual screen identified C9 ...... e myeloma in vitro and in vivo
@en
prefLabel
A virtual screen identified C9 ...... e myeloma in vitro and in vivo
@ast
A virtual screen identified C9 ...... e myeloma in vitro and in vivo
@en
P2093
P2860
P356
P1433
P1476
A virtual screen identified C9 ...... e myeloma in vitro and in vivo
@en
P2093
Chunhua Qiao
Guodong Chen
Jingyu Zhu
Xinliang Mao
Xiumin Zhou
Zubin Zhang
P2860
P304
P356
10.18632/ONCOTARGET.1657
P407
P50
P577
2014-06-01T00:00:00Z